+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Liver Disease Diagnostics Market Size, Share & Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy, Others), End-use (Hospitals, Laboratories, Others), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 80 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5914580
Description Jump to:
The global liver disease diagnostics market size is expected to reach USD 58.62 billion by 2030, expanding at a CAGR of 6.5% from 2023 to 2030, according to the report. increasing funding and research initiatives undertaken by market players is one of the major factors expected to propel market growth. For instance, in November 2019, Glycotest, Inc. received the second USD 3.0 million tranche of USD 10.0 million Series A funding from Shanghai Fosun Pharmaceutical Co., Ltd.(Fosun Pharma). Under this investment, Glycotest, Inc. transferred HCC panel technology to Fosun Pharma to commercialize in China and develop tests for liver cancer and liver fibrosis that are currently under pipeline.

Companies are focusing on collaborations and partnership to improve the quality of care,which is anticipated to drive the market. For instance, in October 2019, Perspectum Diagnostics entered into a partnership to offer LiverMultiScan at Precious Medical Center in Singapore. The aim of this partnership was to create awareness among people to consider liver checking as an integral part of their health screening.

Researchers conducting studies to support the development of novel diagnostic methods that can accurately differentiate between benign and malignant lesions are expected to fuel market growth. For instance, researchers from Charité - Universitätsmedizin Berlin used tomoelastography to visualize mechanical properties of tumors and developed a new Magnetic Resonance Imaging (MRI) technique to detect grading of tumor consistency.

Furthermore, companies are conducting clinical trials to develop new tests with high sensitivity and specificity. For instance, Laboratory for Advanced Medicine is conducting a clinical trial on 1,600 patients with liver cirrhosis using invasive biopsy through quantification of cfDNA methylation and comparing it with ultrasound technique. The test is projected to be completed in 2020.

Development and commercialization of accurate diagnostic methods is expected to boost the market. For instance, in March 2020, ENDRA Life Sciences Inc. received CE mark for TAEUS FLIP system. This system measures liver fat to identify and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). It is an ultrasound system that accurately and at point of care quantifies fat in the liver.

Liver Disease Diagnostics Market Report Highlights

  • The imaging segment accounted for the largest revenue share and is expected to grow at the fastest CAGR. This is attributed to the rising number of initiatives taken by key players in the liver disease diagnostics market to develop advanced imaging techniques.
  • The hospitals segment held the largest revenue share of around 45% in 2022 as the majority of patients rely on hospitals well-equipped with diagnostic testing devices.
  • North America dominated the market and accounted for the largest revenue share of over 40% in 2022 followed by Europe. High investments in R&D and the presence of key players are some factors expected to be responsible for the growth of the market for liver disease diagnostics in the region.
  • Asia Pacific is expected to grow at the fastest CAGR of 8.6% during the forecast period. Increasing geriatric population and awareness about regular check-ups are contributing to the growth of the market for liver disease diagnostics in this region.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Diagnosis technique
1.1.2. End use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Diagnosis technique
2.2.2. End use
2.2.3. Regional scope
2.3. Competitive Insights
Chapter 3. Liver Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Liver Disease Diagnostics Market Analysis Tools
3.4.1. Industry analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Liver Disease Diagnostics: Diagnosis Technique Estimates & Trend Analysis
4.1. Liver Disease Diagnostics Market: Key Takeaways
4.2. Liver Disease Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Imaging
4.3.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Laboratory Tests
4.4.1. Laboratory tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Endoscopy
4.5.1. Endoscopy market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Biopsy
4.6.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Liver Disease Diagnostics: End Use Estimates & Trend Analysis
5.1. Liver Disease Diagnostics Market: Key Takeaways
5.2. Liver Disease Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Laboratories
5.4.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Liver Disease Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Liver Disease Diagnostics Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbott
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. F. Hoffmann-La Roche Ltd.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Thermo Fisher Scientific Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Randox Laboratories Ltd.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Boston Scientific Corporation
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Laboratory Corporation of America Holdings
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Fujifilm Corporation
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Horiba Medical
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Siemens Healthcare GmbH
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 3 North America liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 4 North America liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 6 U.S. liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 8 Canada liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 10 Europe liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 13 Germany liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 15 UK liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 France liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 17 France liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 19 Italy liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 21 Spain liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 Sweden liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 23 Sweden liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Norway liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 25 Norway liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 26 Denmark liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 27 Denmark liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 29 Asia Pacific liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 China liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 32 China liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 Japan liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 34 Japan liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 35 India liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 36 India liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Australia liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 38 Australia liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Thailand liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 40 Thailand liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 South Korea liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 42 South Korea liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 44 Latin America liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Latin America liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 47 Brazil liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 49 Mexico liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 51 Argentina liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 56 South Africa liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 60 UAE liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
Table 62 Kuwait liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Liver disease diagnostics: Market outlook
Fig. 9 Liver disease diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Liver disease diagnostics market driver impact
Fig. 15 Liver disease diagnostics market restraint impact
Fig. 16 Liver disease diagnostics market strategic initiatives analysis
Fig. 17 Liver disease diagnostics market: Diagnosis technique movement analysis
Fig. 18 Liver disease diagnostics market: Diagnosis technique outlook and key takeaways
Fig. 19 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Laboratory tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Endoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Liver disease diagnostics market: End use movement analysis
Fig. 25 Liver disease diagnostics market: End use outlook and key takeaways
Fig. 26 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Global liver disease diagnostics market: Regional movement analysis
Fig. 30 Global liver disease diagnostics market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Profiled

  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories Ltd.
  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages80
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 35.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 58.62 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • Global
From
Global Liver Disease Diagnostics Market by Diagnosis Technique (Biopsy, Endoscopy, Imaging), End-user (Hospitals, Laboratories) - Forecast 2023-2030 - Product Image

Global Liver Disease Diagnostics Market by Diagnosis Technique (Biopsy, Endoscopy, Imaging), End-user (Hospitals, Laboratories) - Forecast 2023-2030

  • Report
  • 187 Pages
  • Global
From
Liver Disease Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Liver Disease Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Global Liver Cancer Diagnostics Market by Test Type (Biopsy, Endoscopy, Imaging), End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories) - Forecast 2024-2030 - Product Image

Global Liver Cancer Diagnostics Market by Test Type (Biopsy, Endoscopy, Imaging), End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories) - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Global Thyroid Function Testing Market Size, Share & Trends Analysis Report by Test Type (TSH Test, T4 Test, T3 Test, Free T4 Test), End-use (Clinics, Diagnostic Laboratories, Hospitals, Research Laboratories & Institutes), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Thyroid Function Testing Market Size, Share & Trends Analysis Report by Test Type (TSH Test, T4 Test, T3 Test, Free T4 Test), End-use (Clinics, Diagnostic Laboratories, Hospitals, Research Laboratories & Institutes), Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.